{"version":"1.2.0","chapters":[{"startTime":0,"title":"Intro"},{"startTime":32.341000000000001,"title":"Begr\u00fc\u00dfung"},{"startTime":226.30099999999999,"title":"Feedback: China"},{"startTime":764.61500000000001,"title":"Feedback: Patente und mRNA-Technologie"},{"startTime":2580.5340000000001,"title":"Infektionszahlen in Deutschland"},{"startTime":3071.3009999999999,"title":"Tests und Positienrate"},{"startTime":3282.6199999999999,"title":"Fortschritt der Impfkampagne"},{"startTime":4571.4560000000001,"title":"WHO erteilt Notfallzulassung f\u00fcr Sinopharm"},{"startTime":4620.0230000000001,"title":"WHO: B.1.617 ist eine Variant of Concern (VoC)"},{"startTime":4692.1750000000002,"title":"USA l\u00e4sst BP f\u00fcr 12-15-j\u00e4hrige zu"},{"startTime":4943.4219999999996,"title":"Digitaler Impfpass"},{"startTime":5378.4949999999999,"title":"Corona-Warn-App"},{"startTime":5468.1989999999996,"title":"\"Krise\" in Taiwan"},{"startTime":5890.5910000000003,"title":"Ausblick"},{"startTime":6315.1300000000001,"title":"Bonus Track"}]}